What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Epilepsy
- Disease
The scientist’s investigation covers issues in Epilepsy, Pediatrics, Surgery, Anesthesia and Neuroscience.
Her Epilepsy research incorporates elements of Encephalopathy, Intellectual disability and Electroencephalography.
Her research in Encephalopathy intersects with topics in Ictal and Hypsarrhythmia.
Catherine Chiron combines subjects such as Hypertonia, Physical therapy and Cognition, Neuropsychology with her study of Pediatrics.
Her work deals with themes such as Prospective memory, Visual memory, Working memory, Short-term memory and Verbal memory, which intersect with Surgery.
Her Anesthesia research is multidisciplinary, incorporating elements of Clinical trial, Phenobarbital, Status epilepticus, Febrile infection related epilepsy syndrome and Adverse effect.
Her most cited work include:
- Changes in regional cerebral blood flow during brain maturation in children and adolescents. (343 citations)
- The right brain hemisphere is dominant in human infants. (290 citations)
- Late plasticity for language in a child's non-dominant hemisphere: a pre- and post-surgery fMRI study. (252 citations)
What are the main themes of her work throughout her whole career to date?
Her primary scientific interests are in Epilepsy, Pediatrics, Anesthesia, Dravet syndrome and Neuroscience.
Her work carried out in the field of Epilepsy brings together such families of science as Surgery, Central nervous system disease and Electroencephalography.
The study incorporates disciplines such as Magnetic resonance imaging, Hypsarrhythmia and Myoclonus in addition to Surgery.
Her study in Pediatrics is interdisciplinary in nature, drawing from both Pharmacokinetics, Encephalopathy, Status epilepticus, Ketogenic diet and Epilepsy syndromes.
Her studies in Anesthesia integrate themes in fields like Adverse effect, Phenobarbital and Circadian rhythm.
Her study in the field of Stiripentol is also linked to topics like In patient.
She most often published in these fields:
- Epilepsy (68.18%)
- Pediatrics (49.59%)
- Anesthesia (30.58%)
What were the highlights of her more recent work (between 2014-2021)?
- Dravet syndrome (26.45%)
- Epilepsy (68.18%)
- Pediatrics (49.59%)
In recent papers she was focusing on the following fields of study:
Catherine Chiron mainly investigates Dravet syndrome, Epilepsy, Pediatrics, Stiripentol and Pharmacokinetics.
Catherine Chiron has included themes like Lennox–Gastaut syndrome, Cognitive delay and Intensive care medicine in her Dravet syndrome study.
Epilepsy is a subfield of Neuroscience that Catherine Chiron investigates.
Her biological study spans a wide range of topics, including Anesthesia, Status epilepticus, Intellectual disability, Ketogenic diet and Epileptic encephalopathy.
The Stiripentol study combines topics in areas such as Adverse effect, Placebo and Randomized controlled trial.
Her research in Pharmacokinetics intersects with topics in Retinal toxicity and Vigabatrin.
Between 2014 and 2021, her most popular works were:
- Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO) : an open-label, dose finding, and feasibility phase 1/2 trial (155 citations)
- Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO) : an open-label, dose finding, and feasibility phase 1/2 trial (155 citations)
- Patients with dravet syndrome in the era of stiripentol: A French cohort cross-sectional study (35 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Epilepsy
- Disease
Her scientific interests lie mostly in Dravet syndrome, Pediatrics, Stiripentol, Pharmacokinetics and Epilepsy.
Her Dravet syndrome research includes elements of Orthopedic surgery, Nerve conduction velocity, Gait Disturbance, Dysmetria and Motor neuron.
Her Pediatrics research incorporates elements of Adverse effect and Patent medicine.
Her study looks at the relationship between Adverse effect and fields such as Anesthesia, as well as how they intersect with chemical problems.
Her Stiripentol research is under the purview of Neuroscience.
Catherine Chiron is studying Clobazam, which is a component of Epilepsy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
